Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Consolidated Net Income (2017 - 2025)

Catheter Precision (VTAK) has disclosed Consolidated Net Income for 9 consecutive years, with -$592000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Consolidated Net Income rose 85.63% to -$592000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$15.9 million, a 36.34% decrease, with the full-year FY2024 number at -$13.5 million, up 80.87% from a year prior.
  • Consolidated Net Income was -$592000.0 for Q3 2025 at Catheter Precision, up from -$8.1 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $3.1 million in Q3 2021 to a low of -$66.4 million in Q1 2023.
  • A 5-year average of -$7.1 million and a median of -$4.2 million in 2024 define the central range for Consolidated Net Income.
  • Peak YoY movement for Consolidated Net Income: soared 142.45% in 2021, then tumbled 1430.64% in 2022.
  • Catheter Precision's Consolidated Net Income stood at -$8.3 million in 2021, then rose by 1.5% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then plummeted by 271.75% to -$2.5 million in 2024, then soared by 76.2% to -$592000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Consolidated Net Income are -$592000.0 (Q3 2025), -$8.1 million (Q2 2025), and -$4.8 million (Q1 2025).